Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.69 USD | +2.17% | +5.57% | -20.09% |
May. 15 | Earnings Flash (CDTX) CIDARA THERAPEUTICS Posts Q1 Revenue $8.5M | MT |
May. 15 | Cidara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 12.2M | Sales 2025 * | 42.86M | Capitalization | 57.89M |
---|---|---|---|---|---|
Net income 2024 * | -85M | Net income 2025 * | -39M | EV / Sales 2024 * | 4.74 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.35 x |
P/E ratio 2024 * |
-0.73
x | P/E ratio 2025 * |
25
x | Employees | 69 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.66% |
Latest transcript on Cidara Therapeutics, Inc.
1 day | +2.17% | ||
1 week | +5.57% | ||
1 month | +7.45% | ||
3 months | -10.91% | ||
6 months | -18.75% | ||
Current year | -20.09% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Preetam Shah
DFI | Director of Finance/CFO | 51 | 21-08-31 |
Les Tari
CTO | Chief Tech/Sci/R&D Officer | 57 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Burgess
CHM | Chairman | 62 | 14-03-31 |
Director/Board Member | 69 | 14-03-31 | |
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 12.69 | +2.17% | 35,316 |
24-05-30 | 12.42 | +5.08% | 38,209 |
24-05-29 | 11.82 | +0.42% | 38,795 |
24-05-28 | 11.77 | -2.08% | 32,988 |
24-05-24 | 12.02 | +0.84% | 29,408 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.09% | 57.89M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- CDTX Stock